Listed

ProPhase Labs, Inc.: Form 10-K for the period ended Dec 31, 2011

Filed with the SEC on Mar 7, 2012 and accepted by EDGAR at Mar 7, 2012, 15:43 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2011-01-01 to 2011-12-31$17.5mus-gaap:SalesRevenueNet
Cost of revenue12 months2011-01-01 to 2011-12-31$6.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2011-01-01 to 2011-12-31$11.3mus-gaap:GrossProfit
Research and development12 months2011-01-01 to 2011-12-31$1.1mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2011-01-01 to 2011-12-31−$2.7mus-gaap:OperatingIncomeLoss
Income tax12 months2011-01-01 to 2011-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-01-01 to 2011-12-31−$2.7mus-gaap:NetIncomeLoss
Operating cash flow12 months2011-01-01 to 2011-12-31−$2.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-01-01 to 2011-12-31$300.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-12-31$5.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$13.2mus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$19.1mus-gaap:Assets
Current liabilitiesAt period end2011-12-31$7.9mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2011-12-31$11.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-013420. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.